Agile Therapeutics, Inc. (AGRX)

NASDAQ: AGRX · IEX Real-Time Price · USD
0.677
-0.006 (-0.84%)
Jul 7, 2022 9:31 AM EDT - Market open

Income Statement (Trailing)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
Revenue
5.754.13.342.050.870.750000000000000000000000000000---0
Revenue Growth (YoY)
564.39%447.53%------------------------------------
Cost of Revenue
11.0810.725.32.591.440.280000000000000000000000000000---0
Gross Profit
-5.34-6.62-1.96-0.54-0.580.470000000000000000000000000000---0
Selling, General & Admin
59.6358.1455.8454.0744.6236.0225.0916.2411.6397.36.937.488.7410.4212.1813.0612.3811.4210.089.148.798.758.377.927.476.766.45.75.154.273.753.473.57---5.93
Research & Development
5.396.257.599.6612.4613.513.3312.0210.149.868.888.078.79.7810.6612.2813.6714.4317.2118.9420.7220.9322.3324.5825.1725.6223.6921.1317.3513.379.657.447.489.15---17.39
Other Operating Expenses
00000000000.30.61.021.020.720.420000000000000000000000
Operating Expenses
65.0264.3963.4363.7357.0849.5238.4228.2621.7718.8616.4815.617.219.5421.824.8826.7326.8128.6329.0229.8729.7231.0832.9533.0933.0930.4527.5323.0418.5213.9211.1910.9512.73---23.32
Operating Income
-70.36-71.01-65.39-64.27-57.66-49.05-38.42-28.26-21.77-18.86-16.48-15.6-17.2-19.54-21.8-24.88-26.73-26.81-28.63-29.02-29.87-29.72-31.08-32.95-33.09-33.09-30.45-27.53-23.04-18.52-13.92-11.19-10.95-12.73----23.32
Interest Expense / Income
3.863.913.823.723.633.112.211.30.400.160.430.751.121.371.561.741.922.082.42.452.452.432.22.22.081.921.761.611.571.551.541.511.51---0.14
Other Expense / Income
-0.01-0.03-0.05-0.09-0.19-0.31-0.37-0.4-0.35-0.25-0.25-0.27-0.33-0.4-0.47-0.44-0.37-0.43-0.37-0.38-0.3-0.35-0.1-0.13-0.21.140.920.940.8-0.35-0.17-0.10.080.08000-0.2
Pretax Income
-74.21-74.89-69.16-67.91-61.1-51.85-40.25-29.16-21.82-18.61-16.4-15.76-17.62-20.26-22.69-26-28.1-28.3-30.34-31.04-32.01-31.82-33.41-35.02-35.09-36.31-33.28-30.22-25.45-19.73-15.3-12.64-12.54-14.32000-23.26
Income Tax
-4.68000000000000-0.48-0.48-0.48-0.480-3.08-3.08-3.08-3.08-5.97-5.97-5.97-5.97-0-0-0-3.65-3.65-3.65-3.650---0
Net Income
-69.54-74.89-69.16-67.91-61.1-51.85-40.25-29.16-21.82-18.61-16.4-15.76-17.62-19.78-22.21-25.52-27.62-28.3-27.27-27.97-28.94-28.74-27.44-29.05-29.11-30.34-33.28-30.22-25.45-16.08-11.65-8.98-8.88-14.32----23.26
Preferred Dividends
0000000000000000000000000000000000---0.6
Net Income Common
-69.54-74.89-69.16-67.91-61.1-51.85-40.25-29.16-21.82-18.61-16.4-15.76-17.62-19.78-22.21-25.52-27.62-28.3-27.27-27.97-28.94-28.74-27.44-29.05-29.11-30.34-33.28-30.22-25.45-16.08-11.65-8.98-8.88-14.32----23.86
Shares Outstanding (Basic)
32222222211111111111111111111000000000
Shares Outstanding (Diluted)
3222222221111111111111111111100000---0
Shares Change
42.20%14.63%7.33%1.69%14.32%71.31%62.94%99.24%105.46%44.05%55.94%27.71%9.00%10.91%7.64%19.01%18.98%9.44%11.07%0.20%7.24%28.41%29.10%29.46%26.05%93.22%19.79%177.53%2488.63%22929.43%---25.20%----
EPS (Basic)
-26.98-30.80-31.20-31.20-28.00-24.40-20.00-16.00-14.40-15.20-16.00-17.20-20.40-23.20-25.60-30.00-34.00-36.40-36.80-38.80-40.00-40.80-40.00-46.00-49.60-55.20-63.20-60.00-63.20-56.40-1.00-4.00-7.00-11.00----24.00
EPS (Diluted)
-26.98-30.80-31.20-31.20-28.00-24.40-20.00-16.00-14.40-15.20-16.00-17.20-20.40-23.20-25.60-30.00-34.00-36.40-36.80-38.80-40.00-40.80-40.00-46.00-49.60-55.20-63.20-60.00-63.20-56.40-1772.00-4.00-7.00-11.00----24.00
Free Cash Flow Per Share
-21.06-26.98-28.24-28.39-24.81-22.51-15.39-10.69-9.85-12.78-11.63-13.09-17.35-20.06-23.77-27.69-30.21-33.45-28.11-31.50-31.43-33.01-35.44-35.23-39.77-46.81-47.17-48.37-40.15-51.25-23.51-36.81-6.00-14.00----30.00
Gross Margin
-92.87%-161.35%-58.79%-26.24%-66.82%62.35%--------------------------------
Operating Margin
-1224.22%-1731.41%-1959.49%-3135.12%-6665.66%-6549.13%--------------------------------
Profit Margin
-1209.94%-1826.24%-2072.43%-3312.63%-7063.35%-6922.96%--------------------------------
Free Cash Flow Margin
-1141.62%-1596.46%-1983.73%-3070.54%-6283.81%-6363.69%--------------------------------
Effective Tax Rate
6.30%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.35%2.10%1.83%1.70%0.00%10.14%9.91%9.61%9.66%17.87%17.05%17.02%16.45%0.00%0.00%0.00%18.51%23.88%28.91%29.13%0.00%---0.00%
EBITDA
-68.08-68.76-63.56-62.9-56.69-48.47-37.86-27.69-21.26-18.44-16.11-15.23-16.81-19.12-21.3-24.42-26.33-26.36-28.24-28.62-29.55-29.35-30.96-32.8-32.87-34.21-31.35-28.45-23.83-18.15-13.74-11.09-11.01-12.8----23.1
EBITDA Margin
-1184.63%-1676.59%-1904.77%-3068.44%-6553.41%-6471.03%--------------------------------
Depreciation & Amortization
2.272.221.781.280.780.280.190.170.160.160.130.090.060.020.030.020.020.020.020.020.020.020.020.020.020.020.020.020.010.010.010.010.010.01---0.02
EBIT
-70.35-70.98-65.34-64.19-57.47-48.74-38.05-27.86-21.42-18.61-16.23-15.33-16.87-19.14-21.32-24.44-26.36-26.39-28.26-28.64-29.57-29.37-30.98-32.82-32.89-34.23-31.36-28.47-23.84-18.16-13.75-11.1-11.02-12.81----23.12
EBIT Margin
-1224.05%-1730.80%-1958.02%-3130.98%-6643.35%-6507.88%--------------------------------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).